4/A
Changes in Ownership
BioXcel Therapeutics, Inc. Filed Acc 0001104659-24-100745
Options or other derivatives
- Chief Commercial Officer acquired 750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-15 | Exercise or conversion : show line 1 in the form Restricted Stock Units | −750 | 8,250 | D |
Loading xslF345X05/tm2424255-4_4aseq1.xml…